کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2893832 | 1172421 | 2009 | 7 صفحه PDF | دانلود رایگان |

Neopterin is released from human monocyte-derived macrophages upon stimulation with interferon-γ and is a sensitive indicator for cellular immune activation. Furthermore, reactive oxygen species (ROS) are produced in case of immune activation and inflammation.In a cross-sectional approach, plasma concentrations of neopterin and of antioxidant compounds and vitamins were compared in 1463 patients investigated by coronary angiography, which were recruited within the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study.Serum neopterin concentrations were higher in patients with coronary artery disease (CAD; mean ± S.D.: 8.7 ± 7.3 nmol/L) compared to controls (7.4 ± 5.0 nmol/L; Welch's t-test: p < 0.001). Mean concentrations of ascorbic acid (p < 0.0001), γ-tocopherol (p < 0.05), lycopene (p < 0.001), lutein + zeaxanthin (p < 0.05), α-carotene (p < 0.05) and β-carotene (p < 0.05) were lower in CAD than in controls. Neopterin concentrations correlated with CAD-score (rs = 0.156; p < 0.0001) and inversely with antioxidants lycopene (rs = −0.277; p < 0.0001) and lutein + zeaxanthin (rs = −0.175; p < 0.0001) levels and with vitamins ascorbic acid (rs = −0.207; p < 0.0001) and α-tocopherol (rs = −0.105; p < 0.0001).The study demonstrates that higher neopterin production is associated with lower concentrations of antioxidant compounds in patients at risk for atherosclerosis. Results suggest that lower concentrations of antioxidant compounds may relate to higher grade of chronic immune activation in patients.
Journal: Atherosclerosis - Volume 202, Issue 2, February 2009, Pages 543–549